This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Precision Oncology by Elliot Ballato
Introduction
Elliot Ballato is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of precision oncology through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of enolase enzymes, which play a crucial role in cancer treatment.
Latest Patents
Elliot Ballato holds a patent for "Inhibitors of the enzyme enolase for precision oncology." This patent includes compounds that are designed to inhibit enolase enzymes, providing new avenues for cancer treatment. The patent outlines various pharmaceutical compositions that incorporate these compounds, along with methods of treatment that utilize them.
Career Highlights
Elliot Ballato is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.
Collaborations
Elliot collaborates with notable colleagues such as Florian Muller and Victoria Yan. Their combined expertise contributes to the innovative research being conducted at the University of Texas System.
Conclusion
Elliot Ballato's contributions to precision oncology through his patent on enolase inhibitors highlight the importance of innovation in medical research. His work exemplifies the potential for scientific advancements to improve cancer treatment outcomes.